Healio: FDA clears investigational new drug application for Zabalafin Hydrogel
Healio: FDA clears investigational new drug application for Zabalafin Hydrogel by Gabrielle M. Grasso NEWS PROVIDED BY Alphyn Biologics February 21, 2025 The investigational new drug application for Zabalafin Hydrogel for the treatment of mild to moderate atopic dermatitis has been cleared by the FDA, Alphyn Biologics announced in a press release. Read the Healio article…